Skip to content

Clinical trials

Carcinoma, Ovarian Epithelial trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Country / region: Japan Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20102
20121
20161
20171
20182
20211
20224
20231
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting5
Active, not recruiting4
Terminated3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Gynecologic Oncology Group2
Japanese Gynecologic Oncology Group2
Novartis Pharmaceuticals2
Amgen1
Bristol-Myers Squibb1
Daiichi Sankyo1
Gynecologic Oncology Trial & Investigation Consortium1
Incyte Corporation1
Kosei Hasegawa, MD, PhD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial21
Ovarian Neoplasms11
Fallopian Tube Neoplasms9
Neoplasms3
Triple Negative Breast Neoplasms3
Breast Neoplasms2
Brenner Tumor2
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Squamous Cell Carcinoma of Head and Neck2

Trials

Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.